Lawstreet Journal

Substantial Unexplained Delay By Drug Authorities In Testing A Sample Can Render Proceedings Under Drugs & Cosmetics Act As Void As Per The Recent Supreme Court Judgement

Lawstreet Journal 12 Aug 2020 4:39pm

Image courtesy: Lawstreet Journal Judiciary Substantial Unexplained Delay By Drug Authorities In Testing A Sample Can Render Proceedings Under Drugs & Cosmetics Act As Void As Per The Recent Supreme Court Judgement

The Hon’ble Supreme Court of India on Wednesday, August 5th, 2020 passed their judgement for the case, Medipol Pharmaceutical India Pvt. Ltd. v/s Post-Graduate Institute of Medical Education & Research, where they observed that in case there is a substantial unexplained delay in examining a sample by the Drug Authorities then any penalty under Drugs and Cosmetics Act,1940 can be rendered as void referring to the evaluation and result of the sample. 

Medipol Pharmaceuticals, a pharma company which was blacklisted for 2 years, initially filed a write petition in Punjab and Harayana High Court which was dismissed, therefore, the company filed an appeal in the Supreme Court of India. The 2- judge bench comprising of Justice R.F. Nariman and Justice Navin Sinha, in the appeal, observed that there was a substantial delay due to which the sample that was sent for testing was beyond its shelf-life by 8 months.

The Apex Court after contemplating precedents concerning the issue of delay in sample analysis under the Drug and Cosmetics Act, Prevention of Food Adulteration Act and Insecticides Act, observed that “they lay down that a valuable right is granted to a person who is penalized under these Acts to have a sample tested by the Government Analyst that is found against such person. The sample is to be tested by a superior or appellate authority, namely, the Central Drugs Laboratory. These judgments lay down that if owing to delay which is predominantly attributable to the State or any of its entities, owing to which an… Continue Reading...


Tagged: Supreme Court of India  
Disclaimer: SoOLEGAL in Media collaboration with Lawstreet Journal. SoOLEGAL take no responsbility for the content provided by Lawstreet Journal. For any discrepancies Contact Lawstreet Journal.
Did you find this write up useful? YES 0 NO 0
Featured Members view all

New Members view all

×

C2RMTo Know More

Something Awesome Is In The Work

0

DAYS

0

HOURS

0

MINUTES

0

SECONDS

Sign-up and we will notify you of our launch.
We’ll also give some discount for your effort :)

* We won’t use your email for spam, just to notify you of our launch.